IndiaTickerLatest filing: Press Release - Natco Pharma Limited
ObservedCompany dossier
Natco Pharma
NSE:NATCOPHARM · ISIN INE987B01026
- Close
- ₹935.95 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Natco Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹474.8 Cr · PAT ₹132.4 Cr.
Exchange XBRLLatest ownership: promoter group 49.42% and public 50.58% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Press Release - Natco Pharma Limited
NSE · exchange filing
Observed
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
BSE · exchange filing
Observed
Source filing Action(s) taken or orders passed - Natco Pharma Limited
NSE · exchange filing
Observed
Source filing Press Release - Natco Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹474.8 Cr
- Profit after tax
- ₹132.4 Cr
- EPS
- ₹7.43
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 49.42%
- Public
- 50.58%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL